Linn Energy Is a Buy
Health Care: Drugs
Salix Pharmaceuticals Ltd. (SLXP: NASDAQ)
$59.47 0.14 | 0.24%
05/22/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with SLXP
- Portfolio NameUser Type
- ContributorDrugs Facing FDA Approval i...
- User7 Stocks with Strong and St...
- ContributorBreakout Stocks Of The Week...
- ProDiscovery Capital Management
- ContributorBreakout Stocks Of The Week...
- Contributor10 Pharma Stocks With Upside
- Contributor10 Biotech Stocks Facing FD...
- UserTop Healthcare Short Squeez...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
Latest SLXP Headlines from TheStreet
- Salix Stock Hits New 52-Week High (SLXP) 05.15.13 | 09:05 am
- Salix Pharmaceuticals Ltd. Stock Upgraded (SLXP) 01.28.13 | 04:01 am
- FDA Places New Heart-Safety Hurdle in Path of Opioid Constipation Drugs 11.12.12 | 10:11 am
- Salix Pharmaceuticals Ltd. Stock Downgraded (SLXP) 11.09.12 | 04:11 am
- Nektar Therapeutics Is a Short 09.12.12 | 07:09 am
- Salix Pharmaceuticals Ltd. (SLXP): Today's Featured Health Care Laggard 08.27.12 | 05:08 pm
- Salix Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.10.12 | 07:08 pm
- 7 Most Reliable Growth Stocks in the Market 08.03.12 | 07:08 am
- Stocks Take Breather After Recent Surge 07.30.12 | 04:07 pm
- Salix Stock Hits New 52-Week High (SLXP) 07.02.12 | 09:07 am
Press Releases for SLXP
- Salix Pharmaceuticals Commits $1.125M To AGA Research Foundation - PR Newswire 03.13.13 | 09:03 am
- Salix Pharmaceuticals Reports 4Q2012 And FY2012 Results - Business Wire 02.28.13 | 04:02 pm
- Salix Pharmaceuticals To Present At Two Investment Conferences In March - Business Wire 02.25.13 | 01:02 pm
- Salix Pharmaceuticals Announces 4Q2012 And FY2012 Financial Results Conference Call And Webcast - Business Wire 02.14.13 | 07:02 am
- FDA Approves Fulyzaq™ (Crofelemer) 125 Mg Delayed-Release Tablets For The Symptomatic Relief Of Diarrhea In Patients With HIV/AIDS On Anti-Retroviral Therapy (ART) - Business Wire 01.02.13 | 07:01 am
- Salix Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 07:01 am
- Salix Pharmaceuticals Previews The American Association For The Study Of Liver Diseases 2012 - Business Wire 11.09.12 | 07:11 am
- Salix Pharmaceuticals Reports 3Q2012 Results - Business Wire 11.07.12 | 04:11 pm
- Salix Pharmaceuticals To Present At Two Investment Conferences In November - Business Wire 11.07.12 | 07:11 am
- Salix Pharmaceuticals Announces 3Q2012 Financial Results Conference Call And Webcast - Business Wire 10.24.12 | 07:10 am
Partner Headlines for SLXP
- Another Delay for Salix Candidate - Analyst Blog - NASDAQ 09.10.12 | 10:09 pm
- Another Delay for Salix Candidate - Analyst Blog - Zacks 09.10.12 | 06:09 pm
- Salix Pharma at Neutral - Analyst Blog - NASDAQ 08.21.12 | 09:08 pm
- Stocks Turn Mixed; Dillard's Breaks Out - Investor's Business Daily 08.09.12 | 11:08 am
- Futures Mixed On Jobs Data; Elizabeth Arden Spikes - Investor's Business Daily 08.09.12 | 09:08 am
- Stocks Extend Gains; Priceline.com Slides After Hours - Investor's Business Daily 08.07.12 | 05:08 pm
- Apple, Other Leaders Shaping Bases In Wild Market - Investor's Business Daily 08.03.12 | 06:08 pm
- Stocks Dip In Lower Volume; Cirrus Logic Soars After Hours - Investor's Business Daily 07.30.12 | 04:07 pm
- Stocks Down In Lower Volume; Salix Pharma Hammered - Investor's Business Daily 07.30.12 | 03:07 pm
- Stock Futures Mixed; Salix, Progenics Tumble - Investor's Business Daily 07.30.12 | 09:07 am
